featured-Reporter

Recruitments bolster personalized medicine initiative

VUMC’s personalized medicine effort is getting a major boost with the recruitment of two physician-scientists from Australia who will increase Vanderbilt’s strength in translational immunology, the translation of basic immunological discoveries into clinically useful tools.

Heart failure therapy shows promise in early clinical trial

Vanderbilt University Medical Center and Acorda Therapeutics Inc. released findings from a Phase 1 clinical trial of glial growth factor 2 (GGF2) last week at the American College of Cardiology Annual Scientific Session in San Francisco.

VUSM ranked among nation’s top schools

Vanderbilt University School of Medicine is once again named among the nation’s elite Research Schools of Medicine in U.S. News & World Report magazine’s 2014 “Best Graduate Schools” rankings, released this week.

Diagnostic management efforts thrive on teamwork

As choices mount for patient testing and treatment, diagnostic management has arisen at Vanderbilt University Medical Center to address two closely related questions that clinicians must ask themselves more and more often: have I ordered the right tests for this patient; and, taken together, what do these test results imply for the best treatment of this patient?

Eye disorder’s genetic risk factors come into focus

An international group of investigators has identified seven new genetic regions associated with age-related macular degeneration (AMD), a common cause of blindness in older individuals.

New signage system points way to ‘tornado safe’ areas

New signs directing Vanderbilt University Medical Center visitors to “tornado safe” areas during a tornado have been placed at Vanderbilt University Hospital, The Vanderbilt Clinic, the Monroe Carell Jr. Children’s Hospital at Vanderbilt and Vanderbilt Health One Hundred Oaks.

1 128 129 130 131 132 151